What is the treatment for hemiplegic migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hemiplegic Migraines

For hemiplegic migraines, acetaminophen and NSAIDs should be used as first-line acute treatments, while flunarizine, sodium valproate, lamotrigine, verapamil, or acetazolamide are recommended as first-line preventive options. 1

Acute Treatment

  • Acetaminophen and NSAIDs are the first choice for acute treatment of hemiplegic migraine attacks 1
  • When common analgesics provide insufficient relief, triptans may be considered, although their use in hemiplegic migraine remains controversial 1
  • Prokinetic antiemetics (domperidone, metoclopramide) can be used as adjunct medications when nausea and vomiting are present 2
  • Avoid ergot alkaloids, opioids, and barbiturates due to questionable efficacy and risk of dependency 2
  • Limit use of acute medications to no more than twice weekly to prevent medication overuse headache 2

Preventive Treatment

Preventive treatment should be considered when:

  • Attack frequency exceeds 2 per month 2, 1
  • Attacks produce significant disability 2
  • Acute treatments fail or are contraindicated 2
  • The patient has hemiplegic migraine (which is considered an uncommon migraine condition requiring prevention) 2

First-line preventive options for hemiplegic migraine:

  • Flunarizine 1
  • Sodium valproate (800-1,500 mg/day) 2, 1
  • Lamotrigine 1
  • Verapamil 1
  • Acetazolamide 1

Second-line preventive options:

  • Topiramate 1
  • Candesartan 1
  • Pizotifen 1

Special considerations:

  • The use of propranolol in hemiplegic migraine is controversial, though recent evidence suggests it may be effective in some cases 1, 3
  • Beta-blockers without intrinsic sympathomimetic activity (like propranolol, timolol) are generally effective for migraine prevention, but their use in hemiplegic migraine requires careful consideration 2, 1
  • For chronic migraine transformation, topiramate, onabotulinumtoxinA, and CGRP monoclonal antibodies have demonstrated effectiveness 2

Treatment Algorithm

  1. Diagnosis confirmation: Ensure diagnosis meets International Classification of Headache Disorders criteria for hemiplegic migraine 4
  2. Acute treatment:
    • Start with acetaminophen or NSAIDs 1
    • Add antiemetics if nausea/vomiting present 2
    • Consider triptans only if other options fail and after careful risk assessment 1
  3. Preventive treatment:
    • Initiate when attacks exceed 2 per month or cause significant disability 2
    • First choice: Select from flunarizine, sodium valproate, lamotrigine, verapamil, or acetazolamide 1
    • Evaluate efficacy after 6-8 weeks at therapeutic doses 5
    • If ineffective, try an alternative first-line agent or consider second-line options 1

Important Considerations

  • Hemiplegic migraine is rare and requires exclusion of other causes of focal neurological symptoms with headache 4
  • Treatment recommendations are largely based on empirical data and expert opinion due to limited clinical trials in this specific population 1, 4
  • Manage comorbidities such as depression, anxiety, and sleep disorders, which can worsen migraine 6
  • Educate patients about avoiding triggers and maintaining regular sleep patterns 6
  • Consider referral to specialist care for difficult-to-manage cases 2

References

Research

Familial and sporadic hemiplegic migraine: diagnosis and treatment.

Current treatment options in neurology, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hemiplegic migraine.

Handbook of clinical neurology, 2024

Research

The acute and preventative treatment of episodic migraine.

Annals of Indian Academy of Neurology, 2012

Guideline

Migraine Risk Factors and Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.